Dr. Rupeena Purewal invites special guest Dr. Ari Bitnun, Professor of Pediatrics at University of Toronto, to discuss CMV in Canada.

Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.

Dr. Rupeena Purewal, pediatric infectious disease physician, reviews Balxoavir Marboxil®, an oral antiviral medication for treatment of influenza A and influenza B flu. Baloxavir® was approved for medical use in Canada in 2020.

Canadian Baloxavir Product Monograph : [Product Monograph Template - Standard] (hres.ca)

Dr. Rupeena Purewal invites special guest Dr. Ameeta Singh, Infectious Diseases Specialist in Edmonton Alberta, to discuss the rising cases of syphilis in Canada.

Dr. Rupeena Purewal, Pediatric Infectious Diseases Physician, summarizes the key findings from the 2020 Canadian Antimicrobial Resistance Surveillance System (CARSS) Report. CARSS is Canada's national system for reporting on antimicrobial use and is one of the Public Health Agency of Canada's commitments as part of the Pan-Canadian framework for action on antimicrobial resistance and antimicrobial use.

Pan-Canadian Action on Antimicrobial Resistance: www.canada.ca/en/public-health/services/publications/drugs-health-products/pan-canadian-action-plan-antimicrobial-resistance.html